EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exon 7 splicing of ERα predicts poor prognosis and increases phenotypic heterogeneity in luminal a subtype breast cancer

Long Wai Tsui, Taobo Hu, Thomson Christian Husein, Wai Hei Shek, Bingrong Chen, Depeng Wang, Shu Wang, Weichuan Yu, Xiaodan Fan, Mengping Long, Toyotaka Ishibashi iD

FEBS Open Bio · 2026

DOI: 10.1002/2211-5463.70215 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEBS Open Bio, 2026. Verfasst von Long Wai Tsui und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Life Science, Hong Kong University of Science & Technology, Hong Kong SAR. Hauptthemen laut MEDLINE: Estrogen Receptor alpha, Breast Neoplasms. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovation and Technology Fund, the Hong Kong Innovation & Technology Commission, National Natural Science Foundation of China, Research Grant Council Hong Kong.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ERαΔ7 is one of the most frequently observed splice variants of the ESR1 gene in breast cancer but its functions remain largely unknown. Here we report that ERαΔ7 predicted poor survival in luminal A type breast cancer from TCGA data. ERαΔ7 occurred more frequently in luminal type breast cancer, with expression inversely correlating with ESR1 expression. Functionally, ERαΔ7‐expressing MCF‐7 cells were found to have lower death rates at the expense of reduced growth and migration, while also being responsive to estrogen deprivation. Furthermore, molecular dynamics simulation showed that estradiol can bind to ERαΔ7. Our study indicated that ERαΔ7 might serve as a potential prognostic marker in Luminal A type breast cancer and has different functions from those of canonical ERα‐expressing cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Estrogen Receptor alphaBreast NeoplasmsHumansFemaleExonsMCF-7 CellsPrognosisAlternative SplicingRNA SplicingGene Expression Regulation, NeoplasticPhenotype

Stichwörter der Autor:innen

breast cancerestrogen receptorsplicingtumor developmenttumor heterogeneity

Substanzen

Estrogen Receptor alphaESR1 protein, human

Autor:innen und Institutionen

  • Division of Life Science, Hong Kong University of Science & Technology, Hong Kong SAR.
  • Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Sweden.
  • GrandOmics Inc, China.
  • Department of Breast Surgery, Peking University People's Hospital, China.
  • Department of Electronics and Computer Engineering, The Hong Kong University of Science & Technology, Hong Kong SAR.
  • Department of Statistics, The Chinese University of Hong Kong, Shatin, Hong Kong SAR.

ORCID-Profile: Toyotaka Ishibashi

Förderung

  • Innovation and Technology Fund, the Hong Kong Innovation & Technology Commission
  • National Natural Science Foundation of China
  • Research Grant Council Hong Kong

Zitieren

APA

Tsui, L. W., Hu, T., Husein, T. C., Shek, W. H., Chen, B., Wang, D., Wang, S., Yu, W., Fan, X., Long, M., & Ishibashi, T. (2026). Exon 7 splicing of ERα predicts poor prognosis and increases phenotypic heterogeneity in luminal a subtype breast cancer. FEBS Open Bio. https://doi.org/10.1002/2211-5463.70215

Vancouver

Tsui LW, Hu T, Husein TC, Shek WH, Chen B, Wang D, et al. Exon 7 splicing of ERα predicts poor prognosis and increases phenotypic heterogeneity in luminal a subtype breast cancer. FEBS Open Bio. 2026. doi:10.1002/2211-5463.70215

BibTeX
@article{Tsui2026,
  author = {Tsui, Long Wai and Hu, Taobo and Husein, Thomson Christian and Shek, Wai Hei and Chen, Bingrong and Wang, Depeng and Wang, Shu and Yu, Weichuan and Fan, Xiaodan and Long, Mengping and Ishibashi, Toyotaka},
  title = {Exon 7 splicing of ERα predicts poor prognosis and increases phenotypic heterogeneity in luminal a subtype breast cancer},
  journal = {FEBS Open Bio},
  year = {2026},
  doi = {10.1002/2211-5463.70215}
}
Kostenlos starten →